Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls

<table>Scatter plot of the MMP-3 concentrations in patients with neurological disorders and healthy controls. The 2 SD cut-off at 48 ng/mL is indicated.</table>

Autoimmune Diseases

fig1

Figure 1

Figure 1: Matrix Metalloproteinase-3 in Myasthenia Gravis Compared to Other Neurological Disorders and Healthy Controls 